Investors such as Pantera Capital and Modular Capital are involved in the DeSci (Decentralized Science) and DAO fields, with tokens like $GENOME and MC totaling $16 million already on the Base chain, now listed on Aerodrome and MEXC.
DeSci, short for Decentralized Science, aims to establish public infrastructure using the Web3 stack to fund, create, review, certify, and store scientific research projects fairly and justly. Despite receiving attention from institutions like Coinbase, Messari, Pfizer, and prominent figures like V God, DeSci has yet to capture the attention of Web3 users compared to the multitude of meme and AI concept coins.
GenomesDAO, an early DeSci project founded in 2018 and launched in 2021, is a biological technology DAO that provides a secure, decentralized, incentive-based genetic testing platform. In light of the data breach incident at the California genetic testing company 23&me, GenomesDAO’s focus on safeguarding user genetic data privacy is crucial. The platform aims to return control of genetic testing data to users, aligning with the vision of Web3 to empower users with ownership and control of their assets.
GenomesDAO operates by offering genetic testing services to users, allowing them to upload their DNA data securely to a database that only they can access. Third-party pharmaceutical companies can apply to use this data by paying with platform tokens, which users can choose to accept in exchange for platform coins as compensation.
Recently, GenomesDAO completed a chain migration to Base and introduced the new platform token $GENOME, which serves as a payment token for third-party companies to access data and as a means for users to unlock disease test reports. Additionally, $GENOME acts as a governance token for the DAO, allowing staking for voting rights and token rewards.
Looking ahead, GenomesDAO shows promise with its viable product, revenue potential, compelling narrative, and dedicated developers. Despite low trading volumes and market capitalization, the project has gained support from Pantera and continues to innovate by collaborating with government and pharmaceutical companies for more data mining opportunities. With the potential for $GENOME to become a profitable investment, securing a DeSci Season is crucial for success, as indicated by the interest of VCs in the project’s future.
